CCM
AMRX icon

Cloud Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Cloud Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16
Closed – – 182
2025
Q3 		$0 Buy
+16
New +$144 ﹤0.01% 1007

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cloud Capital Management's AMRX Position: Q4 2025 in Review

Cloud Capital Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 16 shares.

Cloud Capital Management first reported a position in AMRX in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Cloud Capital Management reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Cloud Capital Management sold 16 Amneal Pharmaceuticals shares in Q4 2025.
  • Cloud Capital Management first reported a position in Amneal Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Cloud Capital Management's Amneal Pharmaceuticals position peaked at $0 in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.